Issues in selecting HCV-infected candidates for anti-viral treatment


  • Anna S. Lok M.D., F.R.C.P.

    Corresponding author
    1. From the University of Michigan Health System, Ann Arbor, MI
    • University of Michigan Medical Center, 3912 Taubman Center, SPC 5362, Ann Arbor, MI 48109
    Search for more papers by this author

  • Potential conflict of interest: Research grants: Abbott, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Roche, Merck; Advisor: Bristol-Myers Squibb, Gilead, GlaxoSmithKline


Watch the interview with the authors

Answer questions and earn CME